Prospective, randomized comparison of ringed and nonringed polytetrafluoroethylene femoropopliteal bypass grafts: A preliminary report Sushil K. Gupta,

Slides:

Advertisements

Similar presentations

Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans Per Örtenwall, MD, PhD *, Hans Wadenvik, MD, PhD **, Jack Kutti, MD, PhD **,

Advertisements

The role of arteriovenous shunts in the pathogenesis of varicose veins Howard C. Baron, M.D., Sebastiano Cassaro, M.D. Journal of Vascular Surgery Volume.

The effect of inguinal lymphatic manipulation on regional lymph flow patterns Jeffrey R. Rubin, MD, Lisa B. Eberlin, MD Journal of Vascular Surgery Volume.

A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease Ramon Berguer, MD, PhD, Mark D. Morasch,

Four years' results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal.

Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial Charles McCollum, MB, ChB, MD, FRCS, Christine Alexander, Dip N, Glenda Kenchington,

Keith D. Calligaro, MD. , Enrico Ascer, MD, Frank J

Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: An analysis of 1275 cases

Richard M. Green, MD, William M

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Lloyd M. Taylor, M.D., Edward S. Phinney, M.D., John M. Porter, M.D.

Surgical complication outcome (SCOUT) score: A new method to evaluate quality of care in vascular surgery James J. Pomposelli, MD, PhD, Sushil K. Gupta,

Surgical management of infected abdominal aortic grafts: Review of a 25-year experience Patrick J. O'Hara, M.D., Norman R. Hertzer, M.D., Edwin G. Beven,

A new valvulotome for in situ bypass grafts

Axillofemoral bypass: A tool with a limited role

Malcolm O. Perry, MD, Richard Kempczinski, MD

Andrea Mingoli, MD, Paolo Sapienza, MD, Richard J

Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: Do the results justify an attempt before bypass grafting? Richard.

Carotid-subclavian bypass grafting with polytetrafluoroethylene grafts for symptomatic subclavian artery stenosis or occlusion: A 20-year experience

Axillopopliteal bypass for limb salvage

Edmond J. Prendiville, MB, FRCSI, Anson Yeager, MD, Thomas F

Lateral approach to the popliteal artery

Peripheral atherectomy with the rotablator: A multicenter report

A prospective randomized trial comparing vein with polytetrafluoroethylene in above- knee femoropopliteal bypass grafting Desiree H.C. Burger, MDa, A.Pieter.

Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial.

Interruption of critical aortoiliac collateral circulation during nonvascular operations: A cause of acute limb-threatening ischemia Alan M. Dietzek,

Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: Results of primary and secondary procedures Hans Schweiger, MD,

Long-term outcome after early infrainguinal graft failure

Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial

Antonio V. Sterpetti, M. D. , Richard D. Schultz, M. D. , Richard J

Kurt R. Wengerter, MD, Frank J. Veith, MD, Sushil K

Philip S. K. Paty, MD, Dhiraj M. Shah, MD, Javid Saifi, MD, Benjamin B

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease Hasan H.

Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency Carlos Eduardo Pereira, MD, Maximiano Albers, MD, PhD, Marcello.

Recreational weight lifting and aortic dissection: Case report

Calvin B. Ernst, MD Journal of Vascular Surgery

The consequences of a failed femoropopliteal bypass grafting: Comparison of saphenous vein and PTFE grafts Mark R. Jackson, MDa, Todd P. Belott, MDa,

Keith D. Calligaro, MD. , Enrico Ascer, MD, Frank J

Anthony D. Whittemore, MD, Magruder C. Donaldson, MD, John A

A modified method for management of prosthetic graft infections involving an anastomosis to the common femoral artery Keith D. Calligaro, MD *, Frank.

Cardiovascular surgery—The rocket and its stars: Presidential address

The fate of the donor artery in extraanatomic revascularization

Endothelial seeding of polytetrafluoroethylene femoral popliteal bypasses: The failure of low-density seeding to improve patency Malcolm Herring, MD,

Composite sequential bypasses to the ankle and beyond for limb salvage

Carlos H. Timaran, MD, Scott L. Stevens, MD, Oscar H

Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial Charles McCollum, MB, ChB, MD, FRCS, Christine Alexander, Dip N, Glenda Kenchington,

James E. Edwards, MD, Lloyd M. Taylor, MD, John M. Porter, MD

A simple technique to protect subcutaneous vein grafts

Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: Six-year results of a randomized clinical trial Gijs J. Aalders,

Angioscopy-guided semiclosed technique for in situ bypass with a novel flushing valvulotome: Early results Peter Stierli, MD, Peter Aeberhard, MD Journal.

Isolated profundaplasty for limb salvage

Stanley Ziomek, M. D. , William J. Quiñones-Baldrich, M. D. , Ronald W

Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a.

Peter G. Kalman, M. D. , Marilyn Hosang, R. N. , Claudio Cina, M. D

Should patient age be a consideration in carotid endarterectomy?

Monitoring vascular surgical performance

Glenn C. Hunter, M.D., Stan N. Carson, M.D.

Homologous veins as an arterial substitute: Long-term results

Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: An analysis of 1275 cases

Long-term results of arterial allograft below-knee bypass grafts for limb salvage: A retrospective multicenter study J.N. Albertini, MD, X. Barral, MD,

D. Emerick Szilagyi, MD—An appreciation

Presidential address: The second-generation vascular surgeon

George D. Lilly 1906–1988 Journal of Vascular Surgery

Determinants of successful peroneal artery bypass

James A. DeWeese, MD Journal of Vascular Surgery

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Innominate artery trauma: A thirty-year experience

Benjamin B. Chang, MD, R. Clement Darling, MD, Devon E. M

Four years' results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal.

Lessons learned in adopting the in situ saphenous vein bypass

Presentation transcript:

Prospective, randomized comparison of ringed and nonringed polytetrafluoroethylene femoropopliteal bypass grafts: A preliminary report Sushil K. Gupta, MD, Franck J. Veith, MD, Harry B. Kram, MD, Kurt R. Wengerter, MD Journal of Vascular Surgery Volume 13, Issue 1, Pages 163-172 (January 1991) DOI: 10.1016/0741-5214(91)90023-N Copyright © 1991 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 1 Cumulative 3-year primary graft patency of ringed and nonringed PTFE femoropopliteal bypass grafts (FP). No significant difference was found between the two groups (p = 0.5). Journal of Vascular Surgery 1991 13, 163-172DOI: (10.1016/0741-5214(91)90023-N) Copyright © 1991 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 2 Cumulative 3-year primary graft patency of above-knee (AK) ringed and nonringed PTFE femoropopliteal bypass grafts. No significant difference was found between the two groups (p = 0.5). Journal of Vascular Surgery 1991 13, 163-172DOI: (10.1016/0741-5214(91)90023-N) Copyright © 1991 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 3 Cumulative 3-year primary graft patency of below-knee (BK) ringed and nonringed PTFE femoropopliteal bypass grafts. No significant difference was found between the two groups (p = 0.5). Journal of Vascular Surgery 1991 13, 163-172DOI: (10.1016/0741-5214(91)90023-N) Copyright © 1991 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 4 Cumulative 3-year primary graft patency of all above-knee (AK) and all below-knee (BK) PTFE femoropopliteal bypass grafts (FEM POPS). The 3-year patency rate of above-knee PTFE femoropopliteal bypass grafts was marginally better than that of below-knee PTFE femoropopliteal bypass grafts (p = 0.25). Journal of Vascular Surgery 1991 13, 163-172DOI: (10.1016/0741-5214(91)90023-N) Copyright © 1991 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions